Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalStockholderEquity,intangibleAssets,capitalSurplus,totalLiab,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,priceHint,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,industry
t0,IDGXF,610236000.0,600000000,,,520000000,,339000000,,639000000,536000000,536000000,103000000,-21000000,,,,181000000,1130000000,594000000,491000000,-16000000,,339000000,339000000,2269991000.0,,,,,,,,,,,,,,,,,,,,,,,,,0,,en-US,US,EQUITY,False,Delayed Quote,0.0,0.93 - 0.93,0.93,finmb_20461623,Other OTC,Integrated Diagnostics Holdings plc,EGP,1093,0,0.11247498,0.13757986,0.817525 - 1.63,-0.7,-0.42944786,0.817525,1.63,USD,4,1.055,-0.12499994,-0.118483365,1.0753239,-0.14532393,-0.13514432,641700032,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.93,1629468752,0.0,0.93,0.93,0.93,6676,INTEGRATED DIAGNOSTICS HLDGS PL,us_market,PRE,0.48,,,1.63,0.8175,1.055,1.0753,1.09k,,600M,,321.02M,28.87%,55.99%,,,,,,0.1,5.87%,,,,74.52%,,"Jul 07, 2021",4:1,"Dec 23, 2020","Dec 30, 2020","Mar 30, 2021",25.29%,0.00%,,,,,126.00%,1.34B,,,,232.40%,,,,22.75,,,,,Value,JE2 3RT,Healthcare,5611,"Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 31, 2020, it operated a network of 481 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.",Saint Helier,44 15 3484 7000,1419984000,Jersey,http://www.idhcorp.com,86400,12 Castle Street,Diagnostics & Research
t-1,IDGXF,610236000.0,600000000,,,412082000,156383000.0,219015000,329090000.0,512576000,410448000,410448000,-269093000,-14851000,,,,177600000,986264000,575816000,473688000,1634000,,234482000,219015000,2269991000.0,399796000.0,1027706000.0,1751036000.0,590766000.0,4177410000.0,1072500000.0,350000.0,652535000.0,275531000.0,1259959000.0,-482750000.0,5423000.0,600130000.0,1009363000.0,25416000.0,-482750000.0,1142278000.0,1360350000.0,9604000.0,276625000.0,363767000.0,67617000.0,100115000.0,178042000.0,0,350987000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.93 - 0.93,0.93,finmb_20461623,Other OTC,Integrated Diagnostics Holdings plc,EGP,1093,0,0.11247498,0.13757986,0.817525 - 1.63,-0.7,-0.42944786,0.817525,1.63,USD,4,1.055,-0.12499994,-0.118483365,1.0753239,-0.14532393,-0.13514432,641700032,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.93,1629468752,0.0,0.93,0.93,0.93,6676,INTEGRATED DIAGNOSTICS HLDGS PL,us_market,PRE,0.48,,,1.63,0.8175,1.055,1.0753,1.09k,,600M,,321.02M,28.87%,55.99%,,,,,,0.1,5.87%,,,,74.52%,,"Jul 07, 2021",4:1,"Dec 23, 2020","Dec 30, 2020","Mar 30, 2021",25.29%,0.00%,,,,,126.00%,1.34B,,,,232.40%,,,,22.75,,,,,Value,JE2 3RT,Healthcare,5611,"Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 31, 2020, it operated a network of 481 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.",Saint Helier,44 15 3484 7000,1419984000,Jersey,http://www.idhcorp.com,86400,12 Castle Street,Diagnostics & Research
t-2,IDGXF,741228000.0,600000000,,,287339000,156383000.0,196232000,-148938000.0,383803000,298132000,298132000,262890000,-17543000,,,,86964000,720313000,422181000,336510000,-10793000,,200375000,196232000,2398772000.0,,,,,,,,,,,,,,,,,,,,,,,,,0,,en-US,US,EQUITY,False,Delayed Quote,0.0,0.93 - 0.93,0.93,finmb_20461623,Other OTC,Integrated Diagnostics Holdings plc,EGP,1093,0,0.11247498,0.13757986,0.817525 - 1.63,-0.7,-0.42944786,0.817525,1.63,USD,4,1.055,-0.12499994,-0.118483365,1.0753239,-0.14532393,-0.13514432,641700032,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.93,1629468752,0.0,0.93,0.93,0.93,6676,INTEGRATED DIAGNOSTICS HLDGS PL,us_market,PRE,0.48,,,1.63,0.8175,1.055,1.0753,1.09k,,600M,,321.02M,28.87%,55.99%,,,,,,0.1,5.87%,,,,74.52%,,"Jul 07, 2021",4:1,"Dec 23, 2020","Dec 30, 2020","Mar 30, 2021",25.29%,0.00%,,,,,126.00%,1.34B,,,,232.40%,,,,22.75,,,,,Value,JE2 3RT,Healthcare,5611,"Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 31, 2020, it operated a network of 481 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.",Saint Helier,44 15 3484 7000,1419984000,Jersey,http://www.idhcorp.com,86400,12 Castle Street,Diagnostics & Research
t-3,IDGXF,741228000.0,600000000,,,116661000,149766000.0,76768000,148938000.0,203197000,117868000,117868000,-91890000,-17457000,,,,44036000,449687000,331819000,246490000,-1207000,,72625000,76768000,2398772000.0,397697000.0,1027706000.0,1282478000.0,339632000.0,3831016000.0,1072500000.0,,679695000.0,207865000.0,1259847000.0,-381129000.0,4683000.0,467429000.0,674778000.0,25417000.0,-381129000.0,1044569000.0,1114365000.0,9855000.0,251956000.0,257795000.0,78908000.0,118202000.0,152790000.0,0,439587000.0,en-US,US,EQUITY,False,Delayed Quote,0.0,0.93 - 0.93,0.93,finmb_20461623,Other OTC,Integrated Diagnostics Holdings plc,EGP,1093,0,0.11247498,0.13757986,0.817525 - 1.63,-0.7,-0.42944786,0.817525,1.63,USD,4,1.055,-0.12499994,-0.118483365,1.0753239,-0.14532393,-0.13514432,641700032,15,America/New_York,EDT,-14400000,PNK,0,False,False,0.93,1629468752,0.0,0.93,0.93,0.93,6676,INTEGRATED DIAGNOSTICS HLDGS PL,us_market,PRE,0.48,,,1.63,0.8175,1.055,1.0753,1.09k,,600M,,321.02M,28.87%,55.99%,,,,,,0.1,5.87%,,,,74.52%,,"Jul 07, 2021",4:1,"Dec 23, 2020","Dec 30, 2020","Mar 30, 2021",25.29%,0.00%,,,,,126.00%,1.34B,,,,232.40%,,,,22.75,,,,,Value,JE2 3RT,Healthcare,5611,"Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. As of December 31, 2020, it operated a network of 481 branch labs. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.",Saint Helier,44 15 3484 7000,1419984000,Jersey,http://www.idhcorp.com,86400,12 Castle Street,Diagnostics & Research
